Steven Cohen
Point72 Asset Management
Steven Cohen, a Wharton School graduate, is considered one of the top hedge fund managers. He founded SAC Capital (later renamed Point72) in 1992. The firm has posted an annualized return of over 30%; in 2023, its flagship fund returned about 11%.
Stock Trading
All
Buys
Sells
No.
Name
Action
Shares Traded
% Change
Shares Held
Mkt Value (Date)
Report Date
Watchlist
Infinite Eagle Acquisition Ord Shs Class A ()
IEAG
New
+1.76M
+50.00%
1.76M
$17.62M
2026-03-10
Korro Bio Inc (US)
KRRO
New
+816.88K
+50.00%
816.88K
$9.03M
2026-03-10
Edesa Biotech Inc (US)
EDSA
New
+600.00K
+50.00%
600.00K
$1.32M
2026-02-24
4
Beta Bionics Inc (US)
BBNX
Buy
+1.30M
+36.20%
2.29M
$28.92M
2026-02-20
5
Q32 Bio Inc (US)
QTTB
New
+1.03M
+50.00%
1.03M
$4.70M
2026-02-18
6
OKYO Pharma Ltd (US)
OKYO
New
+4.06M
+50.00%
4.06M
$6.94M
2026-02-17
7
Dianthus Therapeutics Inc (US)
DNTH
Buy
+1.82M
+37.80%
2.98M
$164.56M
2026-02-13
8
IO Biotech Inc (US)
IOBT
New
+4.03M
+50.00%
4.03M
$1.41M
2026-02-05
9
Precigen Inc (US)
PGEN
Buy
+4.56M
+19.90%
18.29M
$82.10M
2026-01-22
10
Infinite Eagle Acquisition Units (US)
IEAGU
New
+1.76M
+50.00%
1.76M
$18.00M
2026-01-20
